Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
8.55
-0.51 (-5.63%)
At close: Nov 20, 2026, 4:00 PM EST
8.52
-0.04 (-0.41%)
After-hours: Nov 20, 2026, 4:15 PM EST
Adlai Nortye Group Revenue
Adlai Nortye Group had revenue of $13.06M in the half year ending June 30, 2026. This brings the company's total for the last twelve months to $18.06M. In the year 2025, Adlai Nortye Group had annual revenue of $5.00M. That makes Adlai Nortye Group the 34,500th largest company in the world by revenue and 4,527th in the United States.
Revenue (ttm)
$18.06M
Revenue Growth
n/a
P/S Ratio
30.49
Revenue / Employee
$165,651
Employees
109
Market Cap
550.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 45.73M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Geron | 217.52M |
| 4D Molecular Therapeutics | 96.06M |
| Crescent Biopharma | 15.00M |
| Surrozen | 10.53M |
| Aclaris Therapeutics | 6.40M |
| DBV Technologies | 3.74M |
| Entera Bio | 42.00K |
ANL News
- 3 days ago - Adlai Nortye Group Transcript: Jefferies Global Healthcare Conference - Transcripts
- 25 days ago - Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium - GlobeNewsWire
- 5 weeks ago - Adlai Nortye enters CTCSAs with Eli Lilly, Merck KGaA for cetuximab - TheFly
- 5 weeks ago - Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab - GlobeNewsWire
- 7 weeks ago - Adlai Nortye appoints Liu as Head of Investor Relations, Public Relations - TheFly
- 7 weeks ago - Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations - GlobeNewsWire
- 2 months ago - Adlai Nortye Group Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Adlai Nortye initiated with a Buy at Jefferies - TheFly